GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biofrontera AG (XTER:B8FK) » Definitions » Shiller PE Ratio

Biofrontera AG (XTER:B8FK) Shiller PE Ratio : (As of May. 26, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Biofrontera AG Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Biofrontera AG Shiller PE Ratio Historical Data

The historical data trend for Biofrontera AG's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biofrontera AG Shiller PE Ratio Chart

Biofrontera AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Biofrontera AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Biofrontera AG's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Biofrontera AG's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biofrontera AG's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biofrontera AG's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Biofrontera AG's Shiller PE Ratio falls into.



Biofrontera AG Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Biofrontera AG's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Biofrontera AG's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=1.89/123.7729*123.7729
=1.890

Current CPI (Dec. 2023) = 123.7729.

Biofrontera AG Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -1.947 99.543 -2.421
201406 -2.109 99.543 -2.622
201409 -1.947 99.823 -2.414
201412 -1.947 99.543 -2.421
201503 -1.785 99.717 -2.216
201506 -4.364 100.417 -5.379
201509 -1.351 100.417 -1.665
201512 -1.304 99.717 -1.619
201603 -0.373 100.017 -0.462
201606 -1.863 100.717 -2.289
201609 -4.658 101.017 -5.707
201612 -2.383 101.217 -2.914
201703 -1.760 101.417 -2.148
201706 -2.738 102.117 -3.319
201709 -2.711 102.717 -3.267
201712 -0.782 102.617 -0.943
201803 -1.565 102.917 -1.882
201806 -1.956 104.017 -2.327
201809 -2.033 104.718 -2.403
201812 1.565 104.217 1.859
201903 -1.173 104.217 -1.393
201906 5.085 105.718 5.953
201909 -5.155 106.018 -6.018
201912 -1.956 105.818 -2.288
202003 -2.813 105.718 -3.293
202006 0.402 106.618 0.467
202009 -2.397 105.818 -2.804
202012 0.000 105.518 0.000
202103 -1.808 107.518 -2.081
202106 -1.406 108.486 -1.604
202109 -2.030 109.435 -2.296
202112 18.683 110.384 20.949
202203 -10.045 113.968 -10.909
202206 -4.445 115.760 -4.753
202209 -1.890 118.818 -1.969
202212 -0.630 119.345 -0.653
202303 -1.050 122.402 -1.062
202306 0.000 123.140 0.000
202309 -1.050 124.195 -1.046
202312 1.890 123.773 1.890

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Biofrontera AG  (XTER:B8FK) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Biofrontera AG Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Biofrontera AG's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Biofrontera AG (XTER:B8FK) Business Description

Traded in Other Exchanges
Address
Hemmelrather Weg 201, Leverkusen, NW, DEU, 51377
Biofrontera AG is active in the field of healthcare. It manufactures pharmaceutical products, especially medical cosmetics and dermatological drugs for the care and treatment of skin diseases. Its suite of products includes the prescription drugs Ameluz and BF-RhodoLED, for the treatment of actinic keratosis and Belixos, for the regenerative care of reddened and inflamed skin.

Biofrontera AG (XTER:B8FK) Headlines

No Headlines